Omega Therapeutics (OMGA)
US Market

Omega Therapeutics (OMGA) Stock Price & Analysis


OMGA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.98 - $11.98
Previous Close$7.8
Average Volume (3M)98.89K
Market Cap
Enterprise Value$314.63M
Total Cash (Recent Filing)$136.79M
Total Debt (Recent Filing)$22.23M
Price to Earnings (P/E)-3.5
Sep 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.22
Shares Outstanding55,023,089
10 Day Avg. Volume94,440
30 Day Avg. Volume98,894
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)4.27
Price to Sales (P/S)831.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio287.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue135.56
Enterprise Value/Gross Profit-331.53
Enterprise Value/Ebitda-3.03
Price Target Upside51.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Omega Therapeutics’s price range in the past 12 months?
Omega Therapeutics lowest stock price was $1.98 and its highest was $11.98 in the past 12 months.
    What is Omega Therapeutics’s market cap?
    Currently, no data Available
    When is Omega Therapeutics’s upcoming earnings report date?
    Omega Therapeutics’s upcoming earnings report date is Sep 08, 2023 which is in 103 days.
      How were Omega Therapeutics’s earnings last quarter?
      Omega Therapeutics released its earnings results on May 04, 2023. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.587 by $0.087.
        Is Omega Therapeutics overvalued?
        According to Wall Street analysts Omega Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Omega Therapeutics pay dividends?
          Omega Therapeutics does not currently pay dividends.
          What is Omega Therapeutics’s EPS estimate?
          Omega Therapeutics’s EPS estimate is -$0.5.
            How many shares outstanding does Omega Therapeutics have?
            Omega Therapeutics has 55,023,090 shares outstanding.
              What happened to Omega Therapeutics’s price movement after its last earnings report?
              Omega Therapeutics reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.587. Following the earnings report the stock price went up 4.404%.
                Which hedge fund is a major shareholder of Omega Therapeutics?
                Among the largest hedge funds holding Omega Therapeutics’s share is Flagship Pioneering Inc.. It holds Omega Therapeutics’s shares valued at 176M.


                  Omega Therapeutics Stock Smart Score

                  The Omega Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Omega Therapeutics

                  Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.


                  Top 5 ETFs holding OMGA

                  Market Value
                  Smart Score
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold OMGA. The ETFs are listed according to market value of OMGA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  MiMedx Group
                  Organogenesis Holdings
                  PepGen Inc.
                  Kinnate Biopharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis